ArticleOncoTargets and therapy2020

A Hybrid Glioma Tumor Cell Lysate Immunotherapy Vaccine Demonstrates Good Clinical Efficacy in the Rat Model.

Xin-Long Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.